Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.32 USD
Change Today 0.00 / 0.00%
Volume 0.0
XOMA On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John W. Varian

Chief Executive Officer and Director, XOMA Corporation
AgeTotal Calculated CompensationThis person is connected to 27 board members in 2 different organizations across 4 different industries.

See Board Relationships
54$3,039,912
As of Fiscal Year 2014

Background*

Mr. John W. Varian has been the Chief Executive Officer of XOMA Corporation since January 5, 2012. Mr. Varian served as an Interim Chief Executive Officer of XOMA Corporation from August 31, 2011 to January 5, 2012. Mr. Varian served as the Chief Operating Officer of ARYx Therapeutics Inc. from December 2003 to 2011. Mr. Varian served as Chief Financial Officer of ARYx Therapeutics, Inc. from April 2006 to March 10, 2011. Mr. Varian served as a Vice President of Aryx ...

Read Full Background

Corporate Headquarters*

2910 Seventh Street
Berkeley, California 94710

United States

Phone: 510-204-7200
Fax: --

Board Members Memberships*

2008-N/A
Former Director and Member of Audit Committee
2008-Present
Chief Executive Officer and Director
2014-Present
Director and Chairman of Audit Committee

Education*

BBA
Western Michigan University

Other Affiliations*

Annual Compensation*

Salary$569,487
Total Annual Compensation$569,487

Stock Options*

Restricted Stock Awards$1,080,747
All Other Compensation$14,080
Exercised Options110,000
Exercised Options Value$417,635
Exercisable Options555,473
Exercisable Options Value$474,935
Unexercisable Options472,079
Unexercisable Options Value$320,444
Total Value of Options$1,213,014
Total Number of Options1,137,552

Total Compensation*

Total Annual Cash Compensation$848,379
Total Short Term Compensation$569,487
Other Long Term Compensation$1,094,827
Total Calculated Compensation$3,039,912
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XOMA:US $3.32 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Simon E. Moroney Ph.D.Chairman of Management Board and Chief Executive Officer
Morphosys AG
€751.2K
Michael S. O. Oredsson B.Int’l Bus Admin (Lund)Chief Executive Officer and President
BioInvent International AB
kr735.0K
John Peter McLaughlin J.D.Chief Executive Officer, President, Director and Member of Litigation Committee
PDL BioPharma, Inc.
$716.1K
Randal J. Kirk J.D.Chairman, Chief Executive Officer and President
Intrexon Corporation
--
Tim Van Hauwermeiren MSc, EMBAChief Executive Officer and Executive Director
arGEN-X N.V
€362.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XOMA CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.